Southern Research announced today that it has entered into a strategic collaboration with New York-based Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, to support the development of a vaccine, TNX-1800, against the new coronavirus disease, COVID-19, based on Tonix’s proprietary horsepox vaccine platform.
Scientists at Southern Research’s Drug Discovery division have joined the fight against malaria through efforts aimed at discovering new drugs and improving the safety and efficacy of current antimalarial medicines.
Southern Research and Japan’s Ina Research announced today they have formed a partnership that calls for Ina to help connect Southern Research with potential new customers for drug development services in the country with the world’s third largest pharmaceutical industry.
Southern Research announced today that April M. Brys, Ph.D., an experienced life sciences executive with a strong track record in research and leadership roles, has been named vice president of the non-profit organization’s Drug Development division.
How certain bacteria may make people more prone to asthma is one topic of three research grants jointly funded by Southern Research and the UAB School of Medicine. These new research pilots are the latest effort to harness synergies between researchers at the University of Alabama at Birmingham and Southern Research, a Birmingham-based nonprofit research institute with nearly 400 scientists and engineers. The two other pilots seek an improved way to develop new vaccines and a new mouse model for a potentially dangerous, hereditary deficiency shared by 400 million people worldwide.
Scientists at the microbiology lab led by Javier Campos-Gómez, Ph.D., in Drug Discovery at Southern Research discovered that Pseudomonas aeruginosa, a bacterium responsible for severe, drug-resistant infections in humans, uses a family of fatty acids, known as “oxylipins,” in a cell-to-cell signaling language critical for its virulence.
Southern Research’s Stacey Kelpke, Ph.D., believes Birmingham is well equipped to become the next hub for the development of innovative medical devices, thanks to the city’s rich manufacturing heritage and its wide-ranging healthcare expertise,
Southern Research has announced the Transgenic Mouse Human PD-1/L1 Model, its newest service offering in support of immuno-oncology (IO) therapeutic development.
Engineers at Southern Research are helping NASA’s Marshall Space Flight Center explore the capabilities of additive manufacturing technologies that have major logistics implications for the nation’s ambitious future space missions.
The U.S. Department of Energy has selected Southern Research for an award of up to $1.5 million to advance technology for carbon dioxide utilization.
Southern Research has become the first organization in the United States to earn accreditation under ISO 14034, a new international standard for evaluating and verifying environmental technologies that was recently adopted by the American National Standards Institute.
Southern Research and the National Institute of Clean and Low-Carbon Energy (NICE) are collaborating on a project to transform retired electric vehicle batteries into energy storage systems for offices and factories.
Stacey S. Kelpke, Ph.D., an experienced biomedical/bioengineering researcher, has been named program manager of Southern Research's medical device technologies initiative, AIMTech.
Southern Research announced today that accomplished researcher Dr. Babu L. Tekwani has joined the Birmingham-based organization as Distinguished Fellow and Chair of the Infectious Disease Department in Drug Discovery.
Kazutoshi (Kazu) Nakazawa, M.D., Ph.D., whose work has explored how abnormalities in brain circuitry can trigger complex mental disorders, has joined the Southern Research's Neuroscience Department as a Fellow.
Southern Research’s Prosperity Fund is assisting an Alabama startup that sees one of nature’s great recyclers – the black soldier fly – as an instrument to convert chicken poop into high-value products such as protein-rich animal feed and organic fertilizer.
Southern Research scientists are exploring how a mutated protein implicated in prostate cancer plays a role in the development of the disease and whether it holds a key to better treatment outcomes.
The U.S. Department of Energy (DOE) has selected Southern Research for an award of up to $5.9 million to advance production of high-performance, low-cost carbon fibers from biomass.
Southern Research scientists are working on several fronts to help limit the death toll from a catastrophic flu outbreak that one day slams the nation.
Southern Research has been selected to receive nearly $1.7 million in U.S. Department of Energy funding to develop a new, cost-efficient gasifier capable of converting low-grade coal into synthesis gas (syngas) that can be used in a number of applications.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right